SCHEMBL29965617

SCHEMBL29965617

COc1ccc(CSc2cc(Oc3c(Cl)cc(Br)cc3Cl)ncc2OCc2ccccc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 3/20 0.40
CYP2C9 P11712 2/20 0.39
CYP2C19 P33261 2/20 0.39
CYP2E1 P05181 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C8 P10632 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2B6 P20813 1/20 0.39
SIRT2 Q8IXJ6 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
CYP1A2 P05177 1/20 0.38
CTSB P07858 1/20 0.36
PPARG P37231 1/20 0.35
PPARD Q03181 1/20 0.35
PPARA Q07869 1/20 0.35
NPBWR1 P48145 1/20 0.35
GSK3B P49841 1/20 0.35
CDK5 Q00535 1/20 0.35
CDK5R1 Q15078 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23663321 1.00 ABCB1 (0.40) ABCB1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL29965223 0.89 MAPT (0.39) CYP2C9CYP2C19CYP2E1CYP3A4CYP2C8
SCHEMBL23663272 0.89 MAPT (0.39) CYP2C9CYP2C19CYP2E1CYP3A4CYP2C8
SCHEMBL23663502 0.85 MEN1 (0.36) KDM4EALDH1A1
SCHEMBL23663296 0.83 ABCB1 (0.40) ABCB1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL23691521 0.83 LMNA (0.40) KDM4EALDH1A1
SCHEMBL23663291 0.83 CYP2C9 (0.41) ABCB1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL23663294 0.82 CYP2C9 (0.40) ABCB1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL23663289 0.81 ABCB1 (0.49) ABCB1CYP2C9CYP2C19CYP2E1CYP3A4
SCHEMBL29965423 0.81 ABCB1 (0.49) ABCB1CYP2C9CYP2C19CYP2E1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250320197-A1 THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF ECCOGENE INC (US) 2025-10-16 US disclosed
US-12291518-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE INC. (US) 2025-05-06 US disclosed
CN-115244037-B Substituted triazinones as thyroid hormone receptor agonists 诚益生物(美国)公司 2024-10-25 CN disclosed
US-11780825-B2 Thyroid hormone receptor agonists and use thereof ECCOGENE (SHANGHAI) CO., LTD. (CN) 2023-10-10 US disclosed
EP-4090652-A1 SUBSTITUTED TRIAZINONES AS THYROID HORMONE RECEPTOR AGONISTS Eccogene (Shanghai) Co., Ltd. (CN) 2022-11-23 EP disclosed
CN-115244037-A Substituted triazinones as thyroid hormone receptor agonists 上海诚益生物科技有限公司 2022-10-25 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11780825-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB ABCB1 2159/4885CYP2C9 1415/4885CYP2C19 929/4885
US-12291518-B2 Thyroid hormone receptor agonists and use thereof TSHR, THRA, THRB ABCB1 2159/4885CYP2C9 1415/4885CYP2C19 929/4885
US-20250320197-A1 THYROID HORMONE RECEPTOR AGONISTS AND USE THEREOF TSHR, THRA, THRB ABCB1 2159/4885CYP2C9 1415/4885CYP2C19 929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.